News Second Theranos lab fails inspection, faces possibility of m... Sanctions could be imposed regardless of second lab closure.
News Avacta hoping to disrupt antibody drug dominance Avacta is one of several biotechs turning their backs on mabs.
News Abbott unveils next gen point of care diagnostics Abbott hopes for launch of its Alinity suite later this year.
News Theranos unveils new technologies, but concerns linger Desktop testing device and cloud-based diagnostic platform announced.
News Programmable lab-on-chip advancing in trials A digital device the size of a credit card could provide a diagnosis in just minutes for a huge range of conditions.
News Theranos appoints new execs, compliance board Under-fire diagnostics firm tightens regulatory and compliance efforts
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
